Funded Startups in Irvine
Across the 50 most recent Irvine rounds shown, the largest disclosed amount is EnFin’s $325M on 2024-11-21; the next-largest disclosed rounds are $150M (Al…
Across the 50 most recent Irvine rounds shown, the largest disclosed amount is EnFin’s $325M on 2024-11-21; the next-largest disclosed rounds are $150M (Alleviate Financial, 2025-11-03) and $125M (Tarsus Pharmaceuticals, 2025-03-12), so the top value sits well above the rest of the disclosed distribution. Outliers also appear on the low end: the smallest disclosed amount is Sherry’s $110K on 2025-02-03. Dates cluster heavily in the late-2024 window: 2024-10 contains four rounds (e.g., Highlight $10M on 2024-10-08; Turion Space $20M is earlier, while SocialCrowd $3M on 2024-10-24 and Nura Health $3M on 2024-10-23), and the list spans from 2024-01-08 (Second Dinner Studios) through 2025-11-05 (TriMas Aerospace). Sector and stage mix is broad, with repeated “Series Unknown” entries (and several undisclosed amounts), while healthcare and biotechnology are frequent themes (e.g., Tarsus Pharmaceuticals $125M on 2025-03-12; MDxHealth $40M on 2024-09-25; Immunis $16M on 2024-07-01).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out most in round sizes for Irvine, and is there a clear “top of the distribution”?
EnFin’s $325M (2024-11-21) is the only disclosed round above $150M, materially larger than the next disclosed values such as $150M (Alleviate Financial, 2025-11-03) and $125M (Tarsus Pharmaceuticals, 2025-03-12). On the other end, Sherry’s $110K (2025-02-03) is the smallest disclosed amount in the table.
Do these Irvine-funded rounds cluster in a specific time window rather than spreading evenly?
Yes. The densest late-2024 concentration appears around October 2024, which includes multiple entries such as Highlight $10M (2024-10-08), SocialCrowd $3M (2024-10-24), and Nura Health $3M (2024-10-23). The overall date range runs from 2024-01-08 (Second Dinner Studios, $100M) to 2025-11-05 (TriMas Aerospace, undisclosed).
How often are investors not disclosing amounts or using “Series Unknown,” and does that affect what analysts can compare?
The dataset includes both “undisclosed” amounts and “Series Unknown” classifications, which limits size and stage comparability across a meaningful share of entries (e.g., TriMas Aerospace on 2025-11-05 is undisclosed; e-PlanSoft on 2025-09-13 is undisclosed; both sit alongside disclosed rounds like Alleviate Financial $150M on 2025-11-03).
Which sectors appear most repeatedly, and are any outlier-sector bets visible among the biggest rounds?
Healthcare and biotechnology show up repeatedly across disclosed and large rounds: Tarsus Pharmaceuticals $125M (2025-03-12), MDxHealth $40M (2024-09-25), and Immunis $16M (2024-07-01). The largest disclosed round, EnFin $325M (2024-11-21), is in Apps rather than biotech/healthcare, making it a size outlier across the dominant life-sciences theme.
Which “recent” entries fall closest to the most recent dates shown, based on the latest 90-day span?
Using the table’s most recent date (2025-11-05), the most recent ~90 days include rounds like Alleviate Financial $150M (2025-11-03), PlanYear $12M (2025-10-18), and Super73 $5M (2025-10-16). The same window also contains undisclosed entries such as TriMas Aerospace (2025-11-05) and Immerse (2025-08-27).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.